---
title: "Qulipta (atogepant) in preventive treatment of migraine: Indication questions"
description: "Indication questions on Qulipta (atogepant) in preventive treatment of migraine, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Eligibility and Drug names. Questions: What is Qulipta approved for? Is Qulipta approved for chronic migraine? Who is Qulipta for? What is the generic name of Qulipta? 2 further questions follow. 6 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/qulipta--preventive-treatment-of-migraine/indication"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Qulipta (atogepant) in preventive treatment of migraine: Indication questions

Manufacturer: AbbVie Inc.  
Prescribing information: [Qulipta](https://www.rxabbvie.com/pdf/qulipta_pi.pdf)

## Indication

<a id="qulipta-indication"></a>

### What is Qulipta approved for?

> “QULIPTA is indicated for the preventive treatment of migraine in adults.”

Source: [QULIPTA: Prescribing information, page 2, captured 2026-11-14](https://www.rxabbvie.com/pdf/qulipta_pi.pdf#page=2)

> “QULIPTA, or atogepant, is a calcitonin-gene related peptide (CGRP) receptor antagonist approved for the preventive treatment of episodic and chronic migraine in adults.<sup>1</sup>”

Source: [QULIPTA: Frequently Asked Questions for HCPs – QULIPTA® (atogepant), captured 2026-11-14](https://www.quliptahcp.com/frequently-asked-questions#:~:text=QULIPTA%2C%20or%20atogepant%2C%20is%20a,episodic%20and%20chronic%20migraine%20in)

On the page, select: What is QULIPTA?

<a id="qulipta-chronic-migraine-indication"></a>

### Is Qulipta approved for chronic migraine?

Applies to: Preventive treatment of chronic migraine in adults

> “QULIPTA, or atogepant, is a calcitonin-gene related peptide (CGRP) receptor antagonist approved for the preventive treatment of episodic and chronic migraine in adults.<sup>1</sup>”

Source: [QULIPTA: Frequently Asked Questions for HCPs – QULIPTA® (atogepant), captured 2026-11-14](https://www.quliptahcp.com/frequently-asked-questions#:~:text=QULIPTA%2C%20or%20atogepant%2C%20is%20a,episodic%20and%20chronic%20migraine%20in)

On the page, select: What is QULIPTA?

> “The efficacy of QULIPTA for the preventive treatment of chronic migraine in adults was 
> demonstrated in a randomized, multicenter, double-blind, placebo-controlled study (Study 3). 
> The study enrolled patients with at least a 1-year history of chronic migraine, according to the 
> ICHD-3 diagnostic criteria.”

Source: [QULIPTA: Prescribing information, page 17, captured 2026-11-14](https://www.rxabbvie.com/pdf/qulipta_pi.pdf#page=17)

## Eligibility

<a id="qulipta-who-is-it-for"></a>

### Who is Qulipta for?

> “QULIPTA is indicated for the preventive treatment of migraine in adults.”

Source: [QULIPTA: Prescribing information, page 2, captured 2026-11-14](https://www.rxabbvie.com/pdf/qulipta_pi.pdf#page=2)

> “People with migraine, including those with 4 or more monthly migraine days.<sup>1</sup>”

Source: [QULIPTA: Frequently Asked Questions for HCPs – QULIPTA® (atogepant), captured 2026-11-14](https://www.quliptahcp.com/frequently-asked-questions#:~:text=People%20with%20migraine%2C%20including%20those%20with%204%20or%20more%20monthly%20migraine)

On the page, select: Who is QULIPTA for?

> “Safety and effectiveness in pediatric patients have not been established.”

Source: [QULIPTA: Prescribing information, page 7, captured 2026-11-14](https://www.rxabbvie.com/pdf/qulipta_pi.pdf#page=7)

## Drug names

<a id="qulipta-generic-name"></a>

### What is the generic name of Qulipta?

> “QULIPTA<sup>®</sup> (atogepant) tablets, for oral use”

Source: [QULIPTA: Prescribing information, page 1, captured 2026-11-14](https://www.rxabbvie.com/pdf/qulipta_pi.pdf#page=1)

> “The active ingredient of QULIPTA is atogepant, a calcitonin gene-related peptide (CGRP) 
> receptor antagonist.”

Source: [QULIPTA: Prescribing information, page 8, captured 2026-11-14](https://www.rxabbvie.com/pdf/qulipta_pi.pdf#page=8)

<a id="qulipta-drug-class"></a>

### What type of drug is Qulipta (drug class)?

> “QULIPTA is a calcitonin gene-related peptide receptor antagonist indicated 
> for the preventive treatment of migraine in adults. (1)”

Source: [QULIPTA: Prescribing information, page 1, captured 2026-11-14](https://www.rxabbvie.com/pdf/qulipta_pi.pdf#page=1)

> “It is a CGRP receptor antagonist that works by targeting CGRP receptors and blocking CGRP from binding to prevent migraine attacks.”

Source: [QULIPTA: Frequently Asked Questions for HCPs – QULIPTA® (atogepant), captured 2026-11-14](https://www.quliptahcp.com/frequently-asked-questions#:~:text=It%20is%20a%20CGRP%20receptor,binding%20to%20prevent%20migraine%20attacks.)

On the page, select: Is QULIPTA a CGRP?

<a id="qulipta-approval-date"></a>

### When was Qulipta first approved in the US?

> “Initial U.S. Approval: 2021”

Source: [QULIPTA: Prescribing information, page 1, captured 2026-11-14](https://www.rxabbvie.com/pdf/qulipta_pi.pdf#page=1)

## Related pages
- [Medical information: Qulipta (atogepant): Preventive treatment of migraine](https://www.evicenter.com/medical-information/qulipta--preventive-treatment-of-migraine)
- [Pharmacology](https://www.evicenter.com/medical-information/qulipta--preventive-treatment-of-migraine/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/qulipta--preventive-treatment-of-migraine/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/qulipta--preventive-treatment-of-migraine/safety)
- [Specific populations](https://www.evicenter.com/medical-information/qulipta--preventive-treatment-of-migraine/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/qulipta--preventive-treatment-of-migraine/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/qulipta--preventive-treatment-of-migraine/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/qulipta--preventive-treatment-of-migraine/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/qulipta--preventive-treatment-of-migraine/access-and-coverage)
